This inquiry pinpointed osteosarcoma stem cells derived from the OS99-1 cell line, displaying elevated ALDH activity, a trait profoundly dampened by BMP2 treatment both in controlled laboratory conditions and in live subjects (Wang et al. 2011). The gene discussed is BMP2; the disease is osteosarcoma.